Anti-cancer Effects of MW-03, a Novel Indole Compound, by Inducing 15-Hydroxyprostaglandin Dehydrogenase and Cellular Growth Inhibition in the LS174T Human Colon Cancer Cell Line

Author:

Seira Naofumi1,Yanagisawa Naoki1,Suganami Akiko2,Honda Takuya3,Wasai Makiko4,Regan John W.5,Fukushima Keijo6,Yamaguchi Naoto3,Tamura Yutaka2,Arai Takayoshi4,Murayama Toshihiko1,Fujino Hiromichi6

Affiliation:

1. Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University

2. Department of Bioinformatics, Graduate School of Medicine, Chiba University

3. Department of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University

4. Department of Chemistry, Graduate School of Science, Chiba University

5. Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona

6. Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences, Tokushima University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Reference31 articles.

1. 1) Hull MA, Ko SCW, Hawcroft G. Prostaglandin EP receptors: Targets for treatment and prevention of colorectal cancer? Mol. Cancer Ther., 3, 1031–1039 (2004).

2. 2) Eisinger AL, Prescott SM, Jones DA, Stafforini DM. The role of cyclooxygenase-2 and prostaglandins in colon cancer. Prostaglandins Other Lipid Mediat., 82, 147–154 (2007).

3. 3) Brown JR, DuBois J. COX-2: a molecular target for colorectal cancer prevention. J. Clin. Oncol., 23, 2840–2855 (2005).

4. 4) El-sayed MT, Hamdy NA, Osman DA, Ahmed KM. Indoles as anti-cancer agents. Adv. Mod. Oncol. Res., 1, 20–35 (2015).

5. 5) Ahmad A, Sakr WA, Rahman KM. Anticancer properties of indole compounds: mechanism of apoptosis induction and role in chemotherapy. Curr. Drug Targets, 11, 652–666 (2010).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3